Ignyte Acquisition Corp.

Currently, Ignyte Acquisition Corp. does not conduct any significant commercial operations. Its primary objective is to achieve a strategic business combination, which could involve a merger, an exchange of shares, an asset acquisition, a stock purchase, a financial restructuring, a reorganization, or other comparable arrangements with one or more existing enterprises. The company intends to concentrate its search for suitable target businesses within the life sciences, biotechnology, and healthcare industries. Established in 2020, Ignyte Acquisition Corp. maintains its principal office in New York, New York.